Tracking Medicare news, policy, and coverage changes.
(MedPage Today) -- CHICAGO -- A first-in-class bispecific antibody targeting PD-1 and VEGF combined with chemotherapy significantly improved overall survival (OS) in patients with advanced squamous non-small cell lung cancer (NSCLC), according...
Read full article →(MedPage Today) -- Donald Trump's physician says the president is in "excellent health" and is "fully fit" to serve as commander in chief after a medical exam Tuesday at Walter Reed National Military Medical Center that showed the president's body...
Read full article →(MedPage Today) -- CHICAGO -- Treatment with the CDK4/6 inhibitor abemaciclib (Verzenio) offered a dramatic survival uptick in a highly aggressive soft-tissue cancer that rarely responds to chemotherapy, according to the SARC041 trial. Patients...
Read full article →Routine vaccination against IMD is essential to sustaining immunity during the years when young people are at greatest risk.
Read full article →A Florida judge ruled in favor of CVS, Walgreens and Walmart in a lawsuit brought by 16 hospitals accusing the pharmacy retailers of flooding the state with opioids.
Read full article →Health tech companies made several major funding announcements in May. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in May appeared first on MedCity News .
Read full article →Providing access to GLP-1s only solves part of the problem. In fact, without a broader approach, it may lead to new challenges alongside the ones it aims to address. The post Telehealth is Making GLP-1s More Accessible – But Access Alone isn’t Enough appeared first on MedCity News .
Read full article →Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.
Read full article →(MedPage Today) -- CHICAGO -- The adjuvant treatment of RET fusion-positive non-small-cell lung cancer (NSCLC) following potentially curative surgery or radiotherapy has a new standard of care, researchers reported here. In a phase III study...
Read full article →(MedPage Today) -- Peptides have moved from bodybuilding forums into the cultural mainstream. Telehealth clinics advertise them for weight loss and recovery, often outside any FDA-approved indication. Podcasters describe their personal protocols...
Read full article →(MedPage Today) -- CHICAGO -- Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly longer progression-free survival (PFS) with a targeted drug plus an androgen receptor pathway inhibitor...
Read full article →States dealing with budget shortfalls are facing tens of millions of dollars in new costs ahead of the federal Jan. 1 deadline.
Read full article →